Also known as: Sixfold Bioscience
Delivering RNA therapies.
Company is active
Event Year: 2017
Company is active
Event Year: 2017
Sixfold Bioscience is dedicated to advancing the field of RNA therapeutics through the commercialization of its proprietary and patented drug delivery systems. These innovative systems are designed to effectively deliver RNA-based therapies, including small interfering RNAs (siRNAs) for gene silencing and messenger RNAs (mRNAs) for gene expression. By optimizing drug delivery, Sixfold aims to unlock the full potential of RNA therapeutics for treating a wide range of diseases.
Sixfold Bioscience is dedicated to advancing the field of RNA therapeutics through the commercialization of its proprietary and patented drug delivery systems. These innovative systems are designed to effectively deliver RNA-based therapies, including small interfering RNAs (siRNAs) for gene silencing and messenger RNAs (mRNAs) for gene expression. By optimizing drug delivery, Sixfold aims to unlock the full potential of RNA therapeutics for treating a wide range of diseases.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2018
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2018
Healthcare
Healthcare
Healthcare -> Drug Discovery and Delivery
Healthcare -> Drug Discovery and Delivery
Team size: 27
Hiring: No
Team size: 27
Hiring: No
